As the coronavirus pandemic took hold, I for one became more and more worried about previously commonplace activities — such as going to the dentist. And as the financials of Align Technology (NASDAQ: ALGN), the parent company behind Invisalign clear dental aligners, will show, I’m not the only one.
Logic might suggest that Align would have taken a hit in the throes of COVID, because using Invisalign requires a doctor’s note — something it was previously the norm to get at an in-person checkup. But according to the data, it was actually remarkably resilient. As a locked-down economy opens up, management may find themselves in a backlog! Data from the company’s EDGAR filings show that it was able to successfully transition more doctors to a digital interface than had used that interface the year before. This has implications for its future productivity, as well as its current success.